Intervention Review

Nebulised hypertonic saline for cystic fibrosis

  1. Peter Wark1,*,
  2. Vanessa M McDonald2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 16 JUN 2010

Assessed as up-to-date: 30 DEC 2008

DOI: 10.1002/14651858.CD001506.pub3

Database Title

Additional Information

How to Cite

Wark P, McDonald VM. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD001506. DOI: 10.1002/14651858.CD001506.pub3.

Author Information

  1. 1

    Level 3 John Hunter Hospital, Respiratory Medicine HMRI, Newcastle, New South Wales, Australia

  2. 2

    John Hunter Hospital, Department of Respiratory and Sleep Medicine, Newcastle, NSW, Australia

*Peter Wark, Respiratory Medicine HMRI, Level 3 John Hunter Hospital, Locked Bag 1 HRMC, Newcastle, New South Wales, NSW 2310, Australia. peter.wark@hnehealth.nsw.gov.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 JUN 2010

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (380K)Full (485K)

  1. Current Version

    Nebulised hypertonic saline for cystic fibrosis

    Peter Wark and Vanessa M McDonald

    Article first published online: 16 JUN 2010 | DOI: 10.1002/14651858.CD001506.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Nebulised hypertonic saline for cystic fibrosis

    Peter Wark, Vanessa M McDonald and Ashley P Jones

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD001506.pub2

  2. Version 1

    Nebulised hypertonic saline for cystic fibrosis

    PAB Wark and V McDonald

    Article first published online: 18 APR 2005 | DOI: 10.1002/14651858.CD001506

View Full Article (HTML) Summary (59K)Standard (380K)Full (485K)